Enalapril-Associated Anemia in Renal Transplant Recipients Treated for Hypertension
- 1 February 1991
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 17 (2), 199-205
- https://doi.org/10.1016/s0272-6386(12)81129-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Place of Angiotensin-Converting Enzyme Inhibition in the Treatment of Cardiovascular DiseasesNew England Journal of Medicine, 1988
- Converting-Enzyme Inhibitors in the Treatment of HypertensionNew England Journal of Medicine, 1988
- Dynamics of erythropoiesis following renal transplantationKidney International, 1987
- EFFECT OF CYCLOSPORINE AND DELAYED GRAFT FUNCTION ON POSTTRANSPLANTATION ERYTHROPOIESISTransplantation, 1985
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984
- Postrenal transplant erythrocytosis: A review of 53 patientsKidney International, 1983
- ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRITThe Lancet, 1982
- REVERSIBLE LEUCOPENIA ASSOCIATED WITH ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK421The Lancet, 1982
- CAPTOPRIL ASSOCIATED GRANULOCYTOPENIA IN HYPERTENSION AFTER RENAL TRANSPLANTATIONThe Lancet, 1980
- ARE THE NATIVE KIDNEYS RESPONSIBLE FOR ERYTHROCYTOSIS IN RENAL ALLORECIPIENTS?Transplantation, 1979